share_log

Navigating 8 Analyst Ratings For HealthEquity

Navigating 8 Analyst Ratings For HealthEquity

浏览8个healthequity的分析师评级
Benzinga ·  09/20 12:00  · 评级/大行评级
Ratings for HealthEquity (NASDAQ:HQY) were provided by 8 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在过去三个月中,8位分析师为HealthEquity(纳斯达克:HQY)提供了评级,展示了看好和看淡的观点。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级,展示了过去30天内不断变化的情绪,并将其与前几个月进行了比较。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $102.5, with a high estimate of $105.00 and a low estimate of $92.00. Highlighting a 0.49% decrease, the current average has fallen from the previous average price target of $103.00.
分析师对12个月价格目标的评估提供了额外见解,显示出平均目标为102.5美元,高估为105.00美元,低估为92.00美元。当前平均价格比之前的103.00美元的平均价目标下降了0.49%。
Understanding Analyst Ratings: A Comprehensive Breakdown
分析师评级:全面解析
The standing of HealthEquity among financial experts is revealed through an...
通过对最近分析师行动的...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发